Open AccessTreat and extend compared to pro re nata regimen in neovascular age-related macular degeneration
Author(s) -
Rodolfo Garretón,
Raúl González
Publication year - 2020
Publication title -
medwave
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.178
H-Index - 7
ISSN - 0717-6384
DOI - 10.5867/medwave.2020.08.8023
Subject(s) - pro re nata , medicine , macular degeneration , observational study , regimen , ranibizumab , systematic review , medline , adverse effect , family medicine , intensive care medicine , ophthalmology , bevacizumab , chemotherapy , political science , law